Non-invasive Haemodynamic Monitoring in Pregnancy : Comparison Between Ultrasound and Nexfin Technology

Hospital Nord1 site in 1 country55 target enrollmentJanuary 2017

ConditionsPregnancy Related Cardiac Output, High Haemodynamic Instability

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Pregnancy Related
Sponsor: Hospital Nord
Enrollment: 55
Locations: 1
Primary Endpoint: Cardiac output measure
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This prospective and observational trial over 55 pregnant women (third trimester) compares non invasive haemodynamic monitoring using Nexfin technology and ultrasonography technic

Registry

clinicaltrials.gov

Start Date

January 2017

End Date

May 31, 2017

Last Updated

6 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Hospital Nord

Responsible Party

Principal Investigator

marc LEONE

Study Director, Clinical Professor

Hospital Nord

Eligibility Criteria

Inclusion Criteria

•third trimester of pregnancy
•Non-labouring pregnant women
•accepting study

Exclusion Criteria

•refusal of study
•first or second trimester of pregnancy

Outcomes

Primary Outcomes

Cardiac output measure

Time Frame: 30 minutes

Cardiac output is measured with non-invasive digital Nexfin technology (ml/min) and compared with transthoracic echocardiographic measure of cardiac output (ml/min) used as reference. Echographic cardiac output (ml/min) is measured as the produce of cross sectional aera of left ventricular outflow track (cm²) multiplied by velocity time index (cm) multiplied by heart rate (beat/min)